é£²ãæ¥çŒãæ¢ãã®å¹æãæããªã人ã«å ±éãã3ã€ã®ç¿æ £ãšã¯ïŒå¹æãšç ç©¶å ±å
éºäŒåæ€æ»ãæ é€ä»£è¬ãçäœãªãºã ãæé žåé²åŸ¡ç³»ãªã©ãå°éçã«æ¢æ±ããçããŸãžãè¿å¹Žãé£²ãæ¥çŒãæ¢ãããšããŠæ³šç®ããããµããªã¡ã³ãïŒäŸãã°ãPolypodium leucotomosæœåºç©ãã¢ã¹ã¿ããµã³ãã³ãã«ãããã€ãé¡ãªã©ïŒã§ããããæã£ãŠããã®ã«èã®èµ€ã¿ãæ¶ããªãããæ¥çŒãåŸã®å埩ãæã£ãã»ã©æ©ããªãããšãã£ã声ãå°ãªããããŸãããæ¬èšäºã§ã¯ãéºäŒåã»ååã¬ãã«ããã®çè§£ã亀ããªããããé£²ãæ¥çŒãæ¢ãã®å¹æãæãã«ãããªãç¿æ £ããæŽçãããã©ãããã°å®å¹æ§ãé«ãããããïŒwith evidenceïŒããæ¢ããŸãã
é£²ãæ¥çŒãæ¢ããšã¯äœãïŒ
ãŸãããé£²ãæ¥çŒãæ¢ãããšç§°ããããã®ã®æŠå¿µãæŽçããŸããããã§ã¯ãèã®çŽ«å€ç·âèªçºãã¡ãŒãžïŒUV-AïŒUV-BïŒã«å¯ŸããŠãçµå£æåã«ããé²åŸ¡ã»ä¿®åŸ©ä¿é²ãç®æãæ é€ã»æ€ç©æå矀ãæããŸããåŸæ¥ã®ãå¡ãæ¥çŒãæ¢ãïŒå€çšã®SPFïŒPA補å€ïŒããšã¯ç°ãªããå åŽïŒsystemicïŒããã®è£å©çã¢ãããŒãã§ãã
äŸãã°ãããªããã£ãŠã ã»ã¬ãŠã³ãã¢ã¹ïŒPLïŒPolypodium leucotomosïŒæœåºç©ã«ã€ããŠã60æ¥é 240 mg ãïŒæ¥ïŒåæåããã©ã³ãã åäºéç²æ€è©Šéšã§ã¯ãæå°çŽ æéïŒMED: minimal erythema doseïŒãææã«å¢å ããæ¥çŒããšããœãŒãæ°ãæžå°ãããšããå ±åããããŸãã PMC+2Integrative Dermatology Symposium+2 ããã«ã2023幎ã®ã·ã¹ãããã£ãã¯ã¬ãã¥ãŒã§ã¯ããããªãã§ããŒã«ãã«ãããã€ãç³»ãPLãµããªã¡ã³ãã«é¢ããŠæã匷ãå ä¿è·ïŒphotoprotectionïŒãšããã³ã¹ãããããšãŸãšããããŠããŸãã PubMed+2Liebert Publishing+2
ãã®ããã«ãå çæ é€ã¢ãããŒããšããŠã®å¯èœæ§ã¯ãããŸããããä»ã®çæŽ»ç¿æ £ã»éºäŒççŽ å ã»ãµããªã¡ã³ãã®éžã³æ¹ã»äœµçšèŠå ããªã©ãäœçšããŠâ广ã宿ã§ããïŒã§ããªãâãå·Šå³ããŸãã以äžã§ã¯ã宿ãåºã«ãããªãå žåçãªç¿æ £ãïŒç¹ã«åããŠæãäžããŸãã
ç¿æ £â ïŒçŽ«å€ç·æŽé²ïŒä¿è·ãæé©åãããŠããªã
玫å€ç·å¯Ÿçãâ飲ãã ãâã«é Œã£ãŠããŸã
å€ãã®ãé£²ãæ¥çŒãæ¢ããã§å¹æãæãã«ããã±ãŒã¹ã¯ããããã å€çšã»ç°å¢ã»è¡åã«ãã玫å€ç·é²åŸ¡ãäžåå ãšããèæ¯ããããŸããã€ãŸãããµããªã¡ã³ããæã£ãŠããã°å®å¿ããšããèªèããããšãå€çšã®æ¥çŒãæ¢ãïŒSPFïŒPAïŒãç©çé®èœïŒåžœåã»è¡£æã»æ¥åïŒã玫å€ç·æé垯åé¿ïŒæ£åååŸãé¿ããïŒãªã©ã®å®è·µãçããªããã¡ã§ãã ããããç ç©¶ã¬ãã¥ãŒã§ãæèšãããŠããéããçµå£æ é€ã¢ãããŒãã¯ãåŸæ¥ã®ç©çã»ååŠçé²è·ïŒé®èœã»å€çšïŒãè£å©ãããã®ã§ããã代æ¿ã§ã¯ãªãã ãšã PMC+1
ãªãéºäŒåïŒä»£è¬å°éè ã«ãšã£ãŠç¹ã«éèŠã
éºäŒåã¬ãã«ã§èŠããšãäŸãã° MC1R éºäŒåå€åã CDKN2A å€ç°ãªã¹ã¯ä¿æè ïŒã¡ã©ããŒãå®¶ç³»ïŒã§ã¯ã玫å€ç·æåæ§ãé«ããâã€ãŸãåã玫å€ç·éã§ããã¡ãŒãžã倧ããâãšããå ±åããããŸããäŸãã°ãPLæœåºç©ã䜵çšããå ŽåãMC1Rãããã¯CDKN2Aå€ç°ä¿æè ã§âããå·®ãåºãããã£ãâãšããå ±åããããŸãã PMC+1 ãã®èгç¹ããèšãã°ããµããªã飲ãã§ããªããã玫å€ç·é²åŸ¡ã¬ãã«ãäœããŸãŸã ãšããéºäŒçãã€ãªã¹ã¯ â 玫å€ç·æŽé²å€ã âåºç€ãã¡ãŒãžå€ãããšããæ§å³ã«ãªãã广ãçžå¯Ÿçã«âæãã«ããâãªããŸãã
ç¿æ £æ¹åã®ãã€ã³ã
- å€çšã®æ¥çŒãæ¢ãïŒSPF30ïœ50éæãPA++以äžïŒã æ¯æ¥ãé²åºéšäœã«å¡åžã»æ°æéããšã«åå¡åžã
- æ¥åã»åžœåã»é·è¢è¡£ç©ã»ãµã³ã°ã©ã¹ãªã©ç©çé®èœã䜵çšã
- 玫å€ç·ã®ããŒã¯æé垯ïŒéåžž10æã15æïŒãé¿ããïŒå¯èœãªãå±å åé¿ïŒã
- å±å€äœæ¥ãã¹ããŒãæãæµ·ïŒå±±ïŒã¹ããŒïŒé«å°ãªã©åå°ã»æ£ä¹±ãå€ãç°å¢ã§ã¯ãé£²ãæ¥çŒãæ¢ãã®âè£å©å¹æâãšããŠæããŠããã
- éºäŒåæ€æ»ã§çŽ«å€ç·æåæ§ç³»ïŒäŸïŒMC1RãCDKN2AãXPCçïŒãç¢ºèªæžã¿ãªããç¹ã«åæžãã¹ã玫å€ç·æŽé²ãææåã»è¡åèšç»åããã
以äžã®ããã«ãç¿æ £â ã¯ãããããã®çŽ«å€ç·é²åŸ¡ãçããããšã«èµ·å ããâé£²ãæ¥çŒãæ¢ããå¹ããªãâå žåçãªèœãšã穎ã§ãã
ç¿æ £â¡ïŒæé žåïŒä¿®åŸ©æ é€ãçæŽ»ç¿æ £ã§é»å®³ãããŠãã
é£²ãæ¥çŒãæ¢ãïŒæé žåïŒå æå·ä¿®åŸ©ãµããŒããšããçè§£ãæ·±ãã
å è¿°ã®éããé£²ãæ¥çŒãæ¢ãïŒäŸïŒPLæœåºç©ãã«ãããã€ããããªãã§ããŒã«é¡ïŒã¯ã玫å€ç·ãåŒãèµ·ãããæŽ»æ§é žçŽ ïŒROSïŒçæ â DNAæå·ïŒããªããžã³ãã€ããŒåœ¢æãªã©ïŒ âççïŒå èåïŒçºçãªã¹ã¯å¢å ãã®é£éãé ãããã軜æžãããããäœçšããin vitroïŒin vivoã§å ±åãããŠããŸããäŸãã°ãPLã¯çŽ«å€ç·ã«ããCOX-2çºçŸã»iNOSèªå°ã»DNA修埩æå¶ãæãããšãã现èã»åç©ã¬ãã«ã®æ©åºãå ±åãããŠããŸãã MDPI+1 ãŸããã«ãããã€ããã¢ã¹ã¿ããµã³ãã³ãç®èã®æé žåã»ä¿æ¹¿ã»åŒŸåç¶æãžã®å¯äžãå ±åãããŠããŸãã PMC
ããããããã§âçæŽ»ç¿æ £âåŽãæµæå åãšãªããšããã£ããã®ãµããªå¹æãæã¡æ¶ããŠããŸãå¯èœæ§ãé«ããªããŸããäž»ãªé»å®³ç¿æ £ã¯ä»¥äžã®éãã§ãïŒ
- å«ç ã»ååå«ç ïŒäœå ã®æé žååãæ¶èïŒ
- é床ã®é£²é ïŒä»£è¬ã¹ãã¬ã¹å¢å€§ïŒ
- ç¡ç äžè¶³ã»æŒå€é転ã»äº€æ¿å€åïŒä¿®åŸ©ç³»ã»æé žåé µçŽ ç³»ã®æ¥å å€åãªãºã ãä¹±ããïŒ
- é«ã€ã³ã¹ãªã³ïŒé«è¡ç³ã»è¥æºã»æ ¢æ§ççïŒæé žåé²åŸ¡ãã£ãã·ãã£äœäžïŒ
- é£äºãæé žåæåã«ä¹ããïŒéèã»æç©ã»è²çŽ ç³»æ é€çŽ ãå°ãªãïŒ
- é«çŽ«å€ç·ã»é«åå°ç°å¢ã§ã®é·æéæŽé²ïŒä¿®åŸ©æ©æ§ã远ãä»ãããªãïŒ
ããããéãªããšããé£²ãæ¥çŒãæ¢ããæã£ãŠãããã©ãå®éã«ã¯é žåã»ä¿®åŸ©èŠæ±ãéå° âãµããªã§ã«ããŒããããªããç¶æ³ã«ãªããŸãã
éºäŒåã»ä»£è¬å°éèŠç¹ããèŠãé»å®³å å
äŸãã°ãæé žåé µçŽ ã®éºäŒåïŒSOD2ãGPX1ïŒããDNA修埩é¢é£éºäŒåïŒXPCãERCC2ïŒã«å€åãæã£ãŠãã人ã§ã¯ãã平垞æããé žåïŒä¿®åŸ©ã¹ãã¬ã¹ãããé«ãããšããèæ¯ããããããçæŽ»ç¿æ £åŽã§é žåã¹ãã¬ã¹ã»ççè² è·ãäžããããšãããéèŠã§ããã€ãŸããâåæã«ãµããªã§è£ããâãšããçºæ³ã§ã¯ãªããããŸãè² è·ãäžããŠããããããµããªã§å¿æŽããããšããé åºãæ£ãããšèšããŸãã
ç¿æ £æ¹åã®ãã€ã³ã
- çŠç ã»ååå«ç åé¿ã培åºã
- é©é飲é ïŒé±æ°åïŒ1æ¥1æ¯ãªã©ïŒã«å¶éã
- ç¡ç ã®è³ªã»éã確ä¿ïŒ7æé以äžã»äžå®ã®å°±å¯èµ·åºæå»ãå®ãïŒããã³å€éã®äº€æ¿å€åã»æ·±å€èŠéã®åœ±é¿ãã¢ãã¿ãªã³ã°ã
- è¡ç³ã»ã€ã³ã¹ãªã³ã»BMIã»å èèèªãªã©ä»£è¬ããŒã«ãŒã®å®æãã§ãã¯ãé«å€ã®å Žåã¯é£äºïŒéåèšç»ãæ¹ããã
- 飿ãšããŠã¯ãè²ã®æ¿ãéèã»æç©ïŒäŸïŒã±ãŒã«ãã»ãããèãããªãŒé¡ãããããªã³ãã³ïŒã»éïŒãªã¡ã¬-3è±å¯ïŒã»ãããã»å šç²ç©ç©ãæèã
- ãé£²ãæ¥çŒãæ¢ãã飲ãã°å€§äžå€«ããšããèªå·±æç€ºãæšãŠãçæŽ»ç¿æ £ïŒåºç€é²åŸ¡ããµããªïŒè£å©ãšãã圹å²åæ ãæç¢ºã«ããã
ãã®ããã«ãæé žåã»ä¿®åŸ©æ é€ãçæŽ»ç¿æ £é¢ããæŽããŠããªããšããµããªã®å¹æå®æãé端ã«èããªããŸãã
ç¿æ £â¢ïŒãµããªã¡ã³ãã®éžæã»çšæ³ã»äœµçšãæé©åãããŠããªã
æåã»çšéã»ã¿ã€ãã³ã°ã®ãºã¬
ãé£²ãæ¥çŒãæ¢ãããšè¬³ããã補åã«ã¯æ§ã ãªæåã»çšéã»è£œå€åœ¢åŒããããŸããäŸãã°ãPLæœåºç©ã ãã§ãªããã¬ãããªã¬ã³ãžãšãã¹ã»ãã¿ãã³A,C,D,Eé åã®ãµããªçŸ€ã§ã8é±éæåã«ããMEDã23.8%å¢å ãçŽ æåŒ·åºŠïŒÎa*ïŒã46.2%æžå°ãããšããã©ã³ãã åäºéç²æ€ç ç©¶ããããŸãã PubMed+1 ãã ããã®ç ç©¶ã¯ãâè£å©çâ䜿çšãšããŠãæšæºçãªæ¥çŒãé²è·ã䞊è¡ãããäžã§ãã®çµæã§ããçšéã»è£œå€ã»å¯Ÿè±¡èã¿ã€ãã»ããŒã¹é²è·ãéãã°çµæãå€ãããŸãã
æŽã«ãã·ã¹ãããã£ãã¯ã¬ãã¥ãŒã§ã¯ããµããªåäœã§ã®å¹æã¯éçããããç ç©¶æéã»ãµã³ãã«æ°ã»è¢«éšè ã®çŽ«å€ç·æŽé²æ¡ä»¶ã»ä»èŠå ïŒäŸïŒèã¿ã€ãã»éºäŒåå€ç°ïŒã§å€åã倧ããããšæ³šæãããŠããŸãã PubMed+1
ãã®ããã以äžã®ãããªâéžæã»çšæ³ã®ãºã¬âãã广ãæãã«ããããå žåã§ãïŒ
- çšéãæç¢ºã«èšŒæãããéããå°ãªãããŸãã¯äžæç¢ºãªè£œåãéžãã§ããã
- æåã¿ã€ãã³ã°ãææ§ïŒUVæŽé²çŽåïŒæŽé²åŸïŒæ¯æ¥ç¶ç¶ãªã©ïŒã§ãçŽ¯ç©æåæéãçãã
- 補åã®æœåºç©ã»å«ææåãæšæºåãããŠããªãïŒç¹ã«æ€ç©ç±æ¥ãµããªïŒããããããå·®ã»åžåçã»çžäºäœçšãäžæã skin.dermsquared.com
- ä»ã®æ é€ãµããªïŒé«çšéãã¿ãã³Aã»Eã»Î²-ã«ããã³çïŒãè¬å€ãšäœµçšããŠãããçžäºäœçšã»é»å®³ãèµ·ããŠããå¯èœæ§ãäŸãã°ãβ-ã«ããã³åç¬ã«ããç®èããäºé²å¹æã«ã¯éçãå ±åãããŠããŸãã ResearchGate
- ã飲ãã ãã仿¥ã¯æ¥çŒãæ¢ããå¡ããªããŠããããšãã誀èªãããªãã¡ãå€çšé²åŸ¡ãçç¥ããŠããŸãããšã§ããµããªã®è£å©å¹æã远ãã€ããªãã
éºäŒåã»ä»£è¬èгç¹ããã®èæ ®ç¹
éºäŒåæ€æ»ãè¡ã£ãèªè ãªããåžå代è¬ã»æé žåç³»éºäŒåã»ä¿®åŸ©ç³»éºäŒåã»ãã§ãŒãºIïŒIIé µçŽ å€åïŒäŸïŒGSTM1ãNQO1ãXRCC1ïŒã確èªããŠãããããããŸããããããã®å€åãæã£ãŠããå Žåãæšæºçšéã»æšæºè£œå€ã§ãâåå¥åå¿âãå€ããããã以äžã®ãããªã«ã¹ã¿ãã€ãºæ€èšãéèŠã§ãïŒ
- åžåã»ä»£è¬ãè¯ããªããšäºæž¬ãããéºäŒåïŒäŸïŒäœæŽ»æ§ãã¿ãã³ä»£è¬é µçŽ ïŒãä¿æããŠããå Žåãåžåãå¢é²ããé£äºã»è£œå€ïŒäŸïŒèæº¶æ§æåãé£äºãšäžç·ã«æãïŒãéžã¶ã
- 修埩系ãäœæŽ»æ§ãšäºæž¬ãããå Žåããµããªåç¬ã«äŸåãããå€çšé²è·ãšçæŽ»ç¿æ £ã±ã¢ã培åºãããšãããè£åŒ·èšèšããæ©æã«çµãã
- éºäŒåãªã¹ã¯ïŒäŸïŒMC1Rå€ç°ïŒCDKN2Aå€ç°ïŒãæã€å Žåããã®ãªã¹ã¯ã«å¿ããŠããµããªïŒå€çšïŒé®èœïŒçŽ«å€ç·åé¿ãã®ãã«ã»ããæŠç¥ããäžè¬ããã峿 Œã«èšå®ããã
- 䜿çšããŠãããµããªã®èšåºããŒã¿ïŒäŸïŒã©ã®æåã»ã©ã®è¢«éšè 矀ã»ã©ã®çšéã§å¹æãåºããïŒãåºã«ãâèªåã®éºäŒåã»èã¿ã€ãã»æŽé²ç¶æ³âã«è¿ãæ¡ä»¶ãéžã¶ã
ç¿æ £æ¹åã®ãã€ã³ã
- ãµããªãéžã¶éã«ãçšéã»èšåºããŒã¿ïŒMEDå¢å ã»çŽ æè»œæžïŒã»è¢«éšè æ¡ä»¶ïŒèã¿ã€ãã»æŽé²éïŒã»è£œå€æšæºåãã®4ç¹ã確èªã
- æåã¿ã€ãã³ã°ãç¿æ £åããïŒäŸïŒæ¯æé£åŸïŒå€é£åŸããããã¯UVæŽé²å30åïœ1æéïŒããã³æäœ8é±é以äžã¯ç¶ç¶ã
- å€çšæ¥çŒãæ¢ãïŒé®èœè¡åãâå¿ ã䞊è¡âãããããµããªã ãã§ã¯é²åŸ¡ãäžååã
- ä»ã®ãµããªãè¬å€ãšã®äœµçšã«ã€ããŠãåžåé»å®³ã»çžäºäœçšããã§ãã¯ïŒäŸïŒé«çšéβ-ã«ããã³ããã¿ãã³Eéå°ãè¡æ¶²æååºè¬ïŒã
- èªåã®éºäŒåå€åã»èã¿ã€ãã»ç掻è¡åïŒã¢ãŠããã¢é »åºŠãåå°ç°å¢ãé«å°ã»æ°Žäžã»éªäžãªã©ïŒãææ¡ãããäžè¬çè©Šéšæ¡ä»¶ãããã®ã®ã£ãããèªå·±è©äŸ¡ â å¿ èŠãªãå°éå®¶ïŒç®èç§ãæ é€ä»£è¬å°éïŒãšçžè«ã
ãã®ããã«ãç¿æ £â¢ã¯ããµããªã®éžã³æ¹ã»äœ¿ãæ¹ã»äœµçšé¢ä¿ããäžé©åã§ããããã«å¹æãåºã«ãããªããã¿ãŒã³ã§ãã
éºäŒåÃé£²ãæ¥çŒãæ¢ãïŒå°éçèŠç¹ããã®è£è¶³
ãããŸã§ç¿æ £å¥ã«æŽçããŸããããéºäŒåã»ä»£è¬å°éå®¶ã®èŠç¹ããç¹ã«æŒãããŠãããããã€ã³ããæŽçããŸãã
玫å€ç·æåæ§éºäŒåå€å
åè¿°ã®éããMC1Rå€åãCDKN2Aå€ç°ãXPCïŒERCCç³»ä¿®åŸ©é µçŽ å€åãªã©ãååšãããšãåã玫å€ç·éã§ãç®èæå·éã»çºãããªã¹ã¯ãäžæããŸããå®éãPLæœåºç©ãè£å©çã«æåããç ç©¶ã§ã¯ãMC1RïŒCDKN2Aå€ç°ä¿æè ã«ãããŠMEDå¢å 广ãããæç¢ºã ã£ããšããå ±åããããŸãã PMC ã€ãŸãããéºäŒåãã€ãªã¹ã¯çŸ€ïŒãã峿 ŒãªçŽ«å€ç·ç®¡çïŒè£å©ãµããªæŠç¥ããå¿ é ã§ãããç¿æ £â ïœâ¢ã®ã©ãããæ¬ ãããšâé£²ãæ¥çŒãæ¢ãâã®çžå¯Ÿçãªå®å¹æ§ãèœã¡ãŠããŸãã®ã§ãã
æ é€ä»£è¬ã»æé žåé µçŽ éºäŒå
äŸãšããŠSOD2ïŒããã³ã³ããªã¢ã¹ãŒããŒãªãã·ããžã¹ã ã¿ãŒãŒïŒãGPX1ïŒã°ã«ã¿ããªã³ãã«ãªãã·ããŒãŒïŒãNQO1ïŒããã»ããã³ãªãã·ãã¬ãã¯ã¿ãŒãŒïŒãªã©ã®å€åä¿æè ã§ã¯ãåºç€çãªé žåã¹ãã¬ã¹è² è·ãé«ããšãããŠãããè£å©æ é€ïŒãµããªïŒã§âäžä¹ãâããéã»é »åºŠã»äœµçšå¯Ÿçãç°ãªãå¯èœæ§ããããŸãããããå å³ãããçãšåãé£²ã¿æ¹ãããããšã宿ãèããªããŸãã
衚çŸåïŒãã¡ã€ãã¿ã€ãïŒç®èã®åå¿æ§ïŒãšéºäŒåã®é£æº
äŸãã°ãèã¿ã€ãïŒFitzpatrick skin type IâIII vs IVâVIïŒã»éºäŒåãªã¹ã¯ã»æ¥çŒãæŽïŒãµã³ããŒã³çµéšïŒã»ã¢ãŠããã¢æŽ»åéã»åå°ç°å¢ïŒéªäžã»æ°Žäžã»é«å°ãªã©ïŒãçµã¿èŸŒãã âåå¥è©äŸ¡âããé£²ãæ¥çŒãæ¢ãæŠç¥ã§ã¯æ¥µããŠéèŠã§ããç ç©¶ã§ããèæåæ§ãé«ã人ïŒäŸãã°MEDãäœã人ïŒã¯PLãä»ã®å çã¢ãããŒãã®å¹æãããåºãããã£ããšããå ±åããããŸãã PMC+1
ããããèžãŸããšãéºäŒåã»ä»£è¬ã®å°éå®¶èŠç¹ãšããŠã¯ãé£²ãæ¥çŒãæ¢ãã¯ãéºäŒåã»ä»£è¬ã»ç°å¢ã»è¡åãå æ¬ããäºé²æŠç¥ã®äžéšããšããçè§£ãå¿ é ã§ãã端çã«ã¯ãããµããªã ã飲ãã§ããã°ããããšããèãæ¹ã§ã¯éçããããŸãã
ã±ãŒã¹å¥ïŒå¹æãæãã«ãã人ã®âå žåãããã¡ã€ã«â
äžèšïŒã€ã®ç¿æ £ãèžãŸã广ãæãã«ãããªã£ãŠããå žåãã¿ãŒã³ãæŽçããŠãããŸãïŒéºäŒåã»ä»£è¬èŠç¹äœµèšïŒã
ãã¿ãŒã³ AïŒã¢ãŠããã¢é »åºŠé«ïŒé®èœã»å€çšãéïŒéºäŒåãã€ãªã¹ã¯
- 鱿«ã»äŒæ¥ã«é·æéã®å±å€è¡åïŒãŽã«ãã»ããªã³ã¹ããŒãã»å±±å²³ç»å±±ã»ã¹ããŒïŒ
- æ¥çŒãæ¢ãã®åå¡åžãæ ããåžœåã»é·è¢ã»æ¥åãäžåå
- éºäŒåæ€æ»ã§MC1Rå€åã»CDKN2Aå€ç°ãã âãã®å Žåãé£²ãæ¥çŒãæ¢ããæã£ãŠããŠãâé²åŸ¡éïŒè£å©éâãšããæ§å³ã«ãªãã广宿ãåŸã«ãããããã§ã¯ãè¡åå¶åŸ¡ïŒè£å©ãµããªïŒéºäŒåãã€ãªã¹ã¯å¯Ÿå¿èšèšããéµã
ãã¿ãŒã³ BïŒä»£è¬è² è·ã»ç¡ç äžè¶³ã»é£²é ã»å«ç 䜵åïŒãµããªéžææªæé©ïŒéºäŒåäœæŽ»æ§æé žåé µçŽ å€å
- 倿Žããã»äžèŠåå€åã»ç¡ç 5-6æé以äž
- 飲é ã»å«ç ç¿æ £ãããéèã»æç©æåå°ãªã
- åžè²©ã®âé£²ãæ¥çŒãæ¢ã颚âãµããªã1ã2ç¶è©Šãããé åéã»èšåºããŒã¿äžæ
- éºäŒåæ€æ»ã§SOD2ã»GPX1äœæŽ»æ§åä¿æ âãã®å Žåãæé žåã»ä¿®åŸ©è² è·ãé«ãããµããªã®âäžä¹ãéâãè¶³ããŠããªãå¯èœæ§ããŸãåºç€ä»£è¬ç°å¢ãæŽããŠãããç ç©¶ããŒã¿ãæã€ãµããªã«åãæ¿ããã¹ãã
ãã¿ãŒã³ CïŒãµããªæåç¶ç¶æéãçãïŒçšéãå°ãªãïŒå€çšé²åŸ¡çç¥
- é£²ãæ¥çŒãæ¢ããæ°é±é詊ããŠã广ãªããªããšåæ¢
- æåéãå°éããããã¯â1æ¥1åââé£åâãªã©çšéã»ã¿ã€ãã³ã°ãäžæç¢º
- ãå¿ããã¡ããæ¯æ¥ç¶ç¶ã§ããŠããªãã
- æ¥çŒãæ¢ãïŒå€çšïŒãå¡ããªãæ¥ããã âå çã¢ãããŒãã¯çޝç©å¹æã»ç¶ç¶ãéµãç ç©¶ã§ã8é±éä»¥äžæåãã矀ã§MEDå¢å ã»çŽ ææžå°ãæããã«ãªã£ãŠããŸãã PubMed+1
广ãæããããããããã®âç·åãã©ã³â
ãããŸã§ã§ã广ãæããªã人ã«å ±éãã3ã€ã®ç¿æ £ããæŽçããŸãããæåŸã«ãéºäŒåå°éã»æ é€å°éã®èŠç¹ã掻ãããã广ã宿ããããããããã®çµ±åãã©ã³ããææ¡ããŸãã
ã¹ããã1ïŒåºç€ãã§ãã¯ãšãªã¹ã¯æŽç
- éºäŒåæ€æ»ïŒæ¢ã«ä¿æããŠããå Žåã¯å±¥æŽïŒã確èªãMC1RãCDKN2AãSOD2ãGPX1ãXPCãERCC2 çã®å€åæç¡ãæŽçã
- èªèº«ã®èã¿ã€ãïŒFitzpatrick IâVIïŒãæ¥çŒãïŒççæŽãã¢ãŠããã¢é »åºŠã»ç°å¢ïŒæµ·ã»å±±ã»éªã»é«åå°ïŒãæç¢ºåã
- çŸåšã®çæŽ»ç¿æ £ïŒå«ç ã»é£²é ã»ç¡ç ã»é£äºã»éåã»ä»£è¬ããŒã«ãŒïŒãæ£åžããç¹ã«ç¡ç æéã»éèã»æç©æåéã»éåé »åºŠãå®éåã
- çŸåšäœ¿çšäžã®ãµããªïŒè¬å€ïŒå€çšæ¥çŒãæ¢ãã»é®èœè¡åããªã¹ãåã
ã¹ããã2ïŒçŽ«å€ç·é²åŸ¡è¡åã®ã»ããã¢ãã
- æ¯æ¥ã®å€çšæ¥çŒãæ¢ãã®ã«ãŒãã³åïŒé²åºéšäœã«å¿ ãå¡åžã2â3æéããšåå¡åžïŒïŒåžœåã»é®èœç©ã»ã¢ãŠã¿ãŒãã»ããã
- 玫å€ç·ããŒã¯æé垯ã®å±å€æŽ»åå¶éïŒå¯èœãªã10æã15æãé¿ããïŒã
- ã¢ãŠããã¢æã«ã¯âé£²ãæ¥çŒãæ¢ãâãè£å©ãšããŠäœçœ®ã¥ããåç¬é²åŸ¡ã§ã¯ãªãâ2æ¬ç«ãŠâã«ã
ã¹ããã3ïŒæé žåã»ä¿®åŸ©æ é€ç掻ã®åŒ·å
- éèã»æç©ã1æ¥5ã8ãµãŒãã³ã°ïŒéïŒãªã¡ã¬-3ïŒïŒããããç©æ¥µæ¡çšã
- ç¡ç æé7æé以äžã»äžå®ã®å°±å¯èµ·åºæå»ç¶æïŒæ·±å€èŠéã»äº€æ¿å€åãªã¹ã¯ãæå°åã
- å«ç ã»ååå«ç ã»é床飲é ïŒäŸïŒé±3æ¥ä»¥äžã»1æ¥2æ¯ä»¥äžïŒãé¿ããã
- è¡ç³ïŒã€ã³ã¹ãªã³ïŒBMIïŒå èèèªã宿ãã§ãã¯ãã代è¬è² è·ãäœæžããã
ã¹ããã4ïŒé£²ãæ¥çŒãæ¢ããµããªã®éžå®ã»éçš
- 補åéžå®æïŒèšåºããŒã¿ïŒäŸïŒMEDå¢å ïŒçŽ æè»œæžïŒã»çšéã»è£œå€ã®æšæºåïŒæœåºç©å«æéã»è£œé ãããïŒã確èªã
- å°ãªããšã â8é±é以äžç¶ç¶âããæåã¿ã€ãã³ã°ãåºå®ïŒäŸïŒæé£åŸïŒå€é£åŸïŒâç ç©¶ã§ã¯8é±éã§ææå¹æãšããå ±åããã PubMed+1
- å€çšé²åŸ¡ã»é®èœè¡åãšåæéçšã培åºããµããªã ãã«é Œããªãã
- éºäŒåå€åã»èã¿ã€ãã»æŽé²ç°å¢ã«å¿ããŠãå¿ èŠãªã âè£å©å¢éã»äœµçšæ é€â ãå°éå®¶ãšæ€èšã
- 宿çã«å¹æè©äŸ¡ïŒäŸïŒèã®èµ€ã¿ã®åºæ¹ã»çŽ æå埩æéã»è²çŽ æ²çåŸåã»ã¡ã©ãã³ææ°ïŒãè¡ããå幎ã1幎ã«äžåºŠèŠçŽãã
ã¹ããã5ïŒã¢ãã¿ãªã³ã°ïŒèŠçŽã
- 3ã¶æåŸã«ãå€çšé²åŸ¡ïŒé®èœè¡åïŒãµããªç¶ç¶ç¶æ³ã確èªã宿ãä¹ãããã°ãé£äºïŒç¡ç ïŒä»£è¬ææšãåç¹æ€ã
- éºäŒåãªã¹ã¯ä¿æè ïŒäŸïŒMC1Rå€ç°ïŒã§ã¯ããä»ã®è£å©çå é²åŸ¡ïŒäŸïŒå€éã¬ããã€ãïŒæççããã«ã«å€ïŒå°å ¥ããªã©å°éç®èç§ã³ã³ãµã«ãæ€èšã
- ãµããªã®ããã倿Žã»æå倿Žãããå Žåã補åã®ä¿¡é Œæ§ïŒæœåºç©åæïŒç¬¬äžè 詊éšïŒããã§ãã¯ã
广ãå·Šå³ãããå å æ§èŠå ãïŒéºäŒåãšä»£è¬ã®çžäºäœçš
é£²ãæ¥çŒãæ¢ãã®å¹æãåã ã§ç°ãªãæå€§ã®çç±ã®äžã€ã¯ãå å æ§ïŒendogenousïŒãªæé žåã»ä¿®åŸ©èœåã®å·®ã«ãããŸãã ããã¯åã«æ é€ç¶æ ã®éãã§ã¯ãªããéºäŒåå€åã»ããã³ã³ããªã¢æ©èœã»ãã«ã¢ã³ç°å¢ã»å¹Žéœ¢é¢é£å€åãšãã£ãååçççå·®ã«èµ·å ããŸãã
1. æé žåé µçŽ ç³»ã®éºäŒçå€å
ç®èã¯çŽ«å€ç·ç §å°ãåãããšãããã³ã³ããªã¢ã»æ žDNAã»çްèèã«èšå€§ãªé žåã¹ãã¬ã¹ãçºçããŸãããã®ãšããäœå ã§ã¯ä»¥äžã®æé žåé µçŽ ãå³åº§ã«åå¡ãããŸãã
- SODïŒã¹ãŒããŒãªãã·ããžã¹ã ã¿ãŒãŒïŒïŒã¹ãŒããŒãªãã·ããéé žåæ°ŽçŽ ã«å€æ
- CATïŒã«ã¿ã©ãŒãŒïŒïŒéé žåæ°ŽçŽ ãæ°Žã«å€æ
- GPXïŒã°ã«ã¿ããªã³ãã«ãªãã·ããŒãŒïŒïŒè質éé žåãæå¶
ãããã®é µçŽ ã®éºäŒåïŒSOD2ãCATãGPX1ïŒã¯å€åã«ãã£ãп޻æ§ãå人差ã瀺ããŸãã ããšãã°ãSOD2ã®Val16Alaå€åã§ã¯ããã³ã³ããªã¢ãžã®é µçŽ èŒžéå¹çãå€ãããæé žååã30ã40ïŒ äœäžãããšããå ±åããããŸãã ãã®ãããªéºäŒçèæ¯ãæã€äººããé£²ãæ¥çŒãæ¢ãããæåããŠããé žåã¹ãã¬ã¹ã®äžåé床ãé ããççã»çŽ æã»è²çŽ æ²çã®æå¶ãååã«åŸããã«ããåŸåããããŸãã
ãã®å Žåãæé žåæåãåäžã§æãã®ã§ã¯ãªããçžè£çãªæé žåãããã¯ãŒã¯ãæ§ç¯ããå¿ èŠããããŸãã å ·äœçã«ã¯ãSODã®äžæµããµããŒããããã¿ãã³CïŒEïŒÎ±-ãªãé žãã°ã«ã¿ããªã³åçãä¿ãNACïŒN-ã¢ã»ãã«ã·ã¹ãã€ã³ïŒãªã©ãé©éçµã¿åããããšãæé žåã«ãŒããå¹çåããŸãã
2. DNA修埩éºäŒåã®å€åãšå èåèæ§
玫å€ç·ã¯DNAã«ã·ã¯ããã¿ã³åããªããžã³ãã€ããŒïŒCPDïŒã圢æãã転åé»å®³ã»çªç¶å€ç°ã»çްèèåãåŒãèµ·ãããŸãã ãã®ä¿®åŸ©ãæ ãã®ããã¯ã¬ãªããé€å»ä¿®åŸ©ïŒNERïŒçµè·¯ã§ãXPC, XPA, ERCC1/2/5 ãªã©ã®éºäŒåãé¢äžããŸãã ãããã®éºäŒåã«å€ç°ãäœæŽ»æ§å€åãããå Žåãæå·ä¿®åŸ©ãé ããç®èã®ççåå¿ãã¡ã©ãã³ç£çãæç¶ãããããªããŸãã ãã®çµæãé£²ãæ¥çŒãæ¢ãã§æé žåããŠããççâè²çŽ æ²çâã·ã圢æãã®ã«ãŒããå®å šã«æã¡åããªãããšããããŸãã
ãã®ãããªäººã§ã¯ãPLæœåºç©ãªã©DNA修埩ä¿é²äœçšãæã€æåïŒäŸïŒãã§ã«ã©é žã»ã«ããªãªã³ã»ã¢ã¹ã¿ããµã³ãã³ãªã©ïŒãäžå¿ã«çµã¿åãããDNA修埩é床ãåºäžãããæŠç¥ãæå¹ã§ãã
3. ã¡ã©ãã³ä»£è¬ãšéºäŒåå
玫å€ç·ã«å¯ŸãããçŒããããïŒçŒãã«ãããã¯MC1RéºäŒååã«åŒ·ãäŸåããŸãã MC1RïŒã¡ã©ãã³ã«ãã³1å容äœïŒã¯ããã§ãªã¡ã©ãã³ïŒèµ€é»è²ç³»ïŒãšãŠãŒã¡ã©ãã³ïŒé»è€è²ç³»ïŒã®ç£çæ¯ãå¶åŸ¡ããŠããŸãã ãã§ãªã¡ã©ãã³åªäœåã®éºäŒåïŒèµ€æ¯ã»çœèã¿ã€ãïŒã¯ã玫å€ç·åžåèœãäœããæé žååãçžå¯Ÿçã«åŒ±ãåŸåãããã ãé£²ãæ¥çŒãæ¢ããæåããŠãèã®èµ€ã¿ãççãåºããããã±ãŒã¹ãå ±åãããŠããŸãã ãã®ã¿ã€ãã§ã¯ãã«ãããã€ããã¢ã¹ã¿ããµã³ãã³ãªã©å åžåèœãè£ãè²çŽ æ§æé žåç©è³ªã®æåãç¹ã«æå¹ã§ãã
4. ããã³ã³ããªã¢DNAïŒmtDNAïŒå€ç°ãšå èå
玫å€ç·ã«ããmtDNAæå·ã¯ãå 霢æ§ç®èå€åã®äž»èŠå ã§ãã ããã³ã³ããªã¢DNAã¯ä¿®åŸ©é µçŽ ãä¹ãããããäžåºŠæå·ãããšåŒåžéæ©èœãäœäžããROSç£çãå¢å€§âæŽãªãæå·ãšããæªåŸªç°ã«é¥ããŸãã è¿å¹ŽãPLæœåºç©ãã¢ã¹ã¿ããµã³ãã³ãããã³ã³ããªã¢èãå®å®åããé žåãªã³é žåå¹çãç¶æããããšãå ±åãããŠããã ããã³ã³ããªã¢é害ãæã€äººã§ã¯ãã®ç³»ã®ä¿è·ãã广宿ãã«çŽçµããŸãã
ãè žå ç°å¢ããšé£²ãæ¥çŒãæ¢ãåžåã®å¯æ¥ãªé¢ä¿
è¿å¹Žã®ç ç©¶ã§æããã«ãªã£ãŠããã®ããè žå ãããŒã©ãæé žåãµããªã®åžåã»ä»£è¬ãå·Šå³ãããšããäºå®ã§ãã
è žå 代è¬ãšããªãã§ããŒã«æŽ»æ§å
ããªããã£ãŠã ã»ã¬ãŠã³ãã¢ã¹ãã¬ã¹ãã©ãããŒã«ãã¯ããã²ã³é žãªã©ã®æåã¯ããã®ãŸãŸã§ã¯åžåçãäœãã è žå 现èã®ä»£è¬ã«ãã£ãŠãã§ããŒã«é žãããããã·ãããœãŒã«ãªã©ã®æŽ»æ§åã«å€æãããŸãã ãã®è žå 代è¬ã匱ããšãæå¹æåãè¡äžã«ååå±ãããç®èãžã®æé žåã·ã°ãã«ã匱ãŸããŸãã
è žå 现èã®å€æ§æ§ãäœãã»çéèèªé žç£çèãå°ãªãã»æçç©è³ªã®äœ¿çšæŽããã人ã¯ã é£²ãæ¥çŒãæ¢ãã®âå®å¹æ¿åºŠâãäžããå¯èœæ§ããããŸãã
æ¹åã¢ãããŒã
- 氎溶æ§é£ç©ç¹ç¶ïŒã€ããªã³ããªãŒãβã°ã«ã«ã³ãªã©ïŒãæ¯é£æåããè žå èã®ãã©ã³ã¹ãç¶æã
- çºé µé£åïŒãšãŒã°ã«ããçŽè±ãå³åããã ããªã©ïŒã§ä¹³é žèã»ããã£ãºã¹èãè£çµŠã
- æçç©è³ªæçšåŸã¯ãã¬ãã€ãªãã£ã¯ã¹ãæäœ2é±éã
- ãµããªæåæã¯é£åŸã«æãããšã§èæº¶æ§æåïŒã¢ã¹ã¿ããµã³ãã³ããªã³ãã³ãªã©ïŒã®åžåãä¿é²ã
è žå ç°å¢ãæŽããããšã¯ããé£²ãæ¥çŒãæ¢ããå¹ããªãããšãã声ã®èåŸã«ããèŠéãããã¡ãªèŠå ã§ãã
ãæéæ é€åŠããšæåã¿ã€ãã³ã°ã®æé©å
ãµããªã¡ã³ãã®å¹æãæå€§åããã«ã¯ãäœå æèšïŒcircadian rhythmïŒãšæé žåãªãºã ã®åæãéèŠã§ãã
ç®èã®æŠæ¥ãªãºã ãšçŽ«å€ç·èæ§
ç®è现èã«ã¯ç¬èªã®æèšéºäŒåïŒCLOCK, BMAL1, PER1-3ïŒããããæŒå€ã§DNAä¿®åŸ©é µçŽ ãæé žåé µçŽ ã®çºçŸãå€åããŸãã ç ç©¶ã«ããã°ãåå10ã14æã«çŽ«å€ç·æåæ§ãæãé«ããå€éã«ä¿®åŸ©æŽ»æ§ãããŒã¯ã«ãªããŸãã ãããã£ãŠãæé žåæåã®è¡äžæ¿åºŠããååã®æŽé²ããŒã¯ã«åããããããšãçæ³ã§ãã
æé©ãªæåã¿ã€ãã³ã°èšèš
- æé£åŸ30å以å ïŒè質ãå«ãé£äºãšäžç·ã«ïŒïŒèæº¶æ§æåã®åžåãè¯ãã
- UVæŽé²ãäºæ³ãããæ¥ïŒå€åºã®2ã3æéåã«æåããè¡äžæ¿åºŠããŒã¯ãåãããã
- å€ã®æåïŒDNAä¿®åŸ©é µçŽ ã®çºçŸãé«ãŸãå€éã«æé žåæåãè£çµŠãããšã修埩ä¿é²ãæåŸ ã§ããã
ãã®ãããª**ãã¥ã¢ã«ã¿ã€ãã³ã°æåïŒæïŒå€ïŒ**ã¯ãæé žåãªãºã ãè£å®ããæ¥äžé²åŸ¡ïŒå€é修埩ãäž¡ç«ãããç§åŠçæ ¹æ ã«åºã¥ãæ¹æ³ã§ãã
ã代è¬ç°å¢ã®ãã€ãºããæžããæŠç¥
ãµããªã®å¹æãåºã«ãã人ã¯ãæé žå以å€ã®ä»£è¬ãã€ãºãå€ãåŸåããããŸãã ããã§ãããã€ãºãšã¯ãæ ¢æ§ççã»é žåè² è·ã»é«è¡ç³ã»è質ç°åžžã»ç¡ç äžè¶³ã»å¿çã¹ãã¬ã¹ãªã©ã æé žåã·ã¹ãã ãåžžã«ãã«çšŒåãããŠããŸãç°å¢å åãæããŸãã
ççæ§ãã€ãº
è質代è¬ç°åžžãè žå ãªãŒããŒã¬ãããç¶ããšãLPSïŒãªãå€ç³ïŒããµã€ãã«ã€ã³ãäžæããæé žåãµããªã§åŸããã广ãçžæ®ºããŸãã Cåå¿æ§èçœïŒCRPïŒãIL-6ãTNF-αãªã©ã®ççããŒã«ãŒã宿çã«æž¬å®ããããšãæçšã§ãã
é«è¡ç³ãã€ãº
é«è¡ç³ã¯AGEsïŒçµæ«ç³åç£ç©ïŒãçæãã玫å€ç·ã«ããã³ã©ãŒã²ã³æ¶æ©å£åãå éããŸãã ãç³Ã玫å€ç·ãã®çµã¿åããã¯ãå èåãååããããããè¡ç³ç®¡çã¯æ¥µããŠéèŠã ç¹ã«ãçãããªã³ã¯ã»å€é£ã»ç©ºè ¹æé«è¡ç³ãé¿ããããšããé£²ãæ¥çŒãæ¢ãã®å¹æå¢åŒ·ã«çŽçµããŸãã
ã¹ãã¬ã¹ãã«ã¢ã³
æ ¢æ§çã¹ãã¬ã¹ã«ããã³ã«ããŸãŒã«äžæã¯ãã³ã©ãŒã²ã³åææå¶ã»ç®èå ç«äœäžã»ççé·å»¶ããããããŸãã ãã€ã³ããã«ãã¹ã»åŒåžæ³ã»çæéçæ³ãªã©ãã¹ãã¬ã¹å¿çãåãããç¿æ £ãããµããªã®å¹èœãå®å®åãããŸãã
ã女æ§ãã«ã¢ã³ã»ç²ç¶è ºæ©èœããšçŽ«å€ç·æåæ§ã®é¢ä¿
女æ§ã®UVæåæ§ã¯ããšã¹ããã²ã³ãšããã²ã¹ããã³ã®æ¯çã«ã圱é¿ãããŸãã ãšã¹ããã²ã³ã¯ã¡ã©ãã³çæãæå¶ããçç®ã³ã©ãŒã²ã³åæãä¿ãäžæ¹ãããã²ã¹ããã³éå€ã¯ççåå¿ãé«ããåŸåã«ãããŸãã PMSããã«ã¢ã³ãã©ã³ã¹ã®ä¹±ããåŒ·ãææã¯ãé£²ãæ¥çŒãæ¢ããæã£ãŠããèµ€ã¿ããå¹ãåºç©ããè²çŽ æ²çããåºããããªãããã ãã«ã¢ã³åšæã«åãããæåãªãºã ãæŽããã®ãçæ³ã§ãã
ãŸããç²ç¶è ºæ©èœäœäžçã§ã¯ç®è代è¬ã»è¡æµãäœäžããæ é€äŸçµŠãæ»ããããæé žåæåãååã«ç®èã«å±ãã«ãããªããŸãã ãã®ãããªå åæ³ãã©ã³ã¹ã®ãã§ãã¯ãããå¹ããªãåå ãã®äžç«¯ã§ãã
ãååã·ã°ãã«äŒéãããèŠããµããªå¹æã®å人差
æé žåæåã¯åã«ããªãŒã©ãžã«ã«ãæ¶å»ããã ãã§ãªãã现èã·ã°ãã«çµè·¯ã調æŽããŸãã ãããçè§£ããŠãããšãâå¹ããªãâçç±ãããæç¢ºã«èŠããŠããŸãã
NRF2çµè·¯ã®æŽ»æ§å
å€ãã®æ€ç©æ§æé žåç©è³ªïŒãã§ã«ã©é žãã±ã«ã»ãã³ãã¹ã«ãã©ã©ãã¡ã³ãªã©ïŒã¯ã NRF2çµè·¯ã掻æ§åããå å æ§æé žåé µçŽ çŸ€ïŒSOD, HO-1, NQO1ïŒãèªå°ããŸãã ããããNRF2ã®æ žç§»è¡ãé»å®³ããèŠå ïŒäŸïŒéé屿Žé²ãæ ¢æ§ççãé«èèªé£ïŒããããšã æé žåéºäŒåçºçŸãååã«èªå°ãããããµããªã飲ãã§ãåå¿æ§ãéããªããŸãã
NF-κBçµè·¯ã®å¶åŸ¡
玫å€ç·ã«ããæŽ»æ§åããNF-κBçµè·¯ã¯ãççæ§ãµã€ãã«ã€ã³ã®çºçŸãèªå°ããŸãã ããªããã£ãŠã ã»ã¬ãŠã³ãã¢ã¹ãã¢ã¹ã¿ããµã³ãã³ã¯NF-κBæå¶äœçšãæã¡ãŸããã æ ¢æ§ã¹ãã¬ã¹ãç³åãç¶ããšNF-κBãåžžã«æŽ»æ§åãããµããªã®é®éäœçšãçžæ®ºãããŸãã ãã®å Žåã**æççåé£äºãã¿ãŒã³ïŒäœGIã»é«ããªãã§ããŒã«ã»ãªã¡ã¬3èèªé žïŒ**ãäžå¯æ¬ ã§ãã
ãåžåé»å®³ã»çžäºäœçšãã«ããèŠããªãèœãšã穎
ã©ãã»ã©åªããæåã§ããåžåãããªããã°æå³ããããŸããã ãŸããä»ã®ãµããªãè¬å€ãšã®äœµçšãåžåã»ä»£è¬ãé»å®³ããŠããã±ãŒã¹ãå€ãèŠãããŸãã
å žåçãªé»å®³ãã¿ãŒã³
- éãµããªïŒããªãã§ããŒã«ïŒéãããªãã§ããŒã«ãšãã¬ãŒãããåžåãé»å®³ã
- ã«ã«ã·ãŠã ïŒäºéïŒãã°ãã·ãŠã ïŒæé žåãµããªã®åææåïŒéå±ã€ãªã³ç«¶åã«ããåžåäœäžã
- é«çšéãã¿ãã³AïŒÎ²-ã«ããã³ïŒçžäºåžåé»å®³ã«ãããã¿ãã³Eå¹æãæžåŒ±ã
- ç·è¶ã»ã³ãŒããŒçŽåŸã®ãµããªæåïŒã¿ã³ãã³ãã«ãã§ã€ã³ãåžåã劚ããã
ããããé¿ããã«ã¯ãæåã¿ã€ãã³ã°ã2ã3æéãããããå颿åãã«ãŒã«ãç¿æ £åããããšãéèŠã§ãã
ãç¶ç¶æéãšèç©å¹æãïŒçæéã§ã¯èŠããªãå€å
é£²ãæ¥çŒãæ¢ãã®äœçšã¯å³å¹æ§ã§ã¯ãªãã环ç©çïŒcumulativeïŒãªçްèé²åŸ¡åã®åäžã§ãã å€ãã®èšåºè©Šéšã¯8ã12é±é以äžã®ç¶ç¶ãåæãšããŠããã çæéã§ãå€åããªãããšçµè«ããã®ã¯ææå°æ©ã§ãã
玫å€ç·é²åŸ¡å¹æã¯ãç®èäžã®æé žåç©è³ªæ¿åºŠïŒã«ãããã€ãéãã°ã«ã¿ããªã³æ¿åºŠãDNAä¿®åŸ©é µçŽ æŽ»æ§ãªã©ïŒãäžå®å€ãè¶ ããŠåããŠé¡åšåããŸãã ãã®ãããå°ãªããšã8é±é以äžã®é£ç¶æåïŒç¶ç¶çãªå€çšé²åŸ¡ãååã§ãã äžæã»åéãç¹°ãè¿ããšãè¡äžæ¿åºŠãä¹±ããå®å®ããå é²åŸ¡ãåŸãããŸããã
ãŸãšã
é£²ãæ¥çŒãæ¢ãã®å¹æãæããªã人ã«ã¯ãå ±éããŠã玫å€ç·å¯Ÿçã®åãããæé žåã»ä¿®åŸ©ã劚ããçæŽ»ç¿æ £ããæåéžæã»æåæ³ã®èª€ãããšãã3ã€ã®èŠå ããããŸããéºäŒçãªæé žååãDNA修埩èœã®éããè žå ç°å¢ã»ç¡ç ã»ä»£è¬ã»ãã«ã¢ã³ãªã©ã®å çèŠçŽ ã圱é¿ããŸããéèŠãªã®ã¯ããµããªãâäžèœé²åŸ¡âãšèª€è§£ãããå€çšé²åŸ¡ã»çæŽ»ç¿æ £ã»éºäŒåç¹æ§ãçµ±åããå€å±€çã±ã¢ãè¡ãããšãç§åŠçæ ¹æ ã«åºã¥ããæåéžæãšç¶ç¶çãªæåããçã®ãã©ããããã¯ã·ã§ã³å¹æãåŒãåºãéµã§ãã